527 related articles for article (PubMed ID: 17074346)
1. A comparison of oral and transdermal short-term estrogen therapy in postmenopausal women with metabolic syndrome.
Chu MC; Cosper P; Nakhuda GS; Lobo RA
Fertil Steril; 2006 Dec; 86(6):1669-75. PubMed ID: 17074346
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin, and ghrelin.
Chu MC; Cosper P; Orio F; Carmina E; Lobo RA
Am J Obstet Gynecol; 2006 Jan; 194(1):100-4. PubMed ID: 16389017
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome in postmenopausal women: the influence of oral or transdermal estradiol on inflammation and coagulation markers.
Chu MC; Cushman M; Solomon R; Lobo RA
Am J Obstet Gynecol; 2008 Nov; 199(5):526.e1-7. PubMed ID: 18511016
[TBL] [Abstract][Full Text] [Related]
4. Endothelin levels decrease after oral and nonoral estrogen in postmenopausal women with increased cardiovascular risk factors.
Wilcox JG; Hatch IE; Gentzschein E; Stanczyk FZ; Lobo RA
Fertil Steril; 1997 Feb; 67(2):273-7. PubMed ID: 9022602
[TBL] [Abstract][Full Text] [Related]
5. Correlation between estrogens and serum adipocytokines in premenopausal and postmenopausal women.
Hong SC; Yoo SW; Cho GJ; Kim T; Hur JY; Park YK; Lee KW; Kim SH
Menopause; 2007; 14(5):835-40. PubMed ID: 17667144
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome after menopause and the role of hormones.
Lobo RA
Maturitas; 2008 May; 60(1):10-8. PubMed ID: 18407440
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin and resistin serum levels in women with polycystic ovary syndrome during oral glucose tolerance test: a significant reciprocal correlation between adiponectin and resistin independent of insulin resistance indices.
Lewandowski KC; Szosland K; O'Callaghan C; Tan BK; Randeva HS; Lewinski A
Mol Genet Metab; 2005 May; 85(1):61-9. PubMed ID: 15862282
[TBL] [Abstract][Full Text] [Related]
8. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
Araújo DA; Farias ML; Andrade AT
Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
[TBL] [Abstract][Full Text] [Related]
9. Plasma adiponectin levels in postmenopausal women with or without long-term hormone therapy.
Im JA; Lee JW; Lee HR; Lee DC
Maturitas; 2006 Apr; 54(1):65-71. PubMed ID: 16198517
[TBL] [Abstract][Full Text] [Related]
10. Effects on serum lipid and leptin levels of three different doses of norethisterone continuously combined with a fixed dose of 17beta-estradiol for nasal administration in postmenopausal women: a controlled, double-blind study.
Castelo-Branco C; Palacios S; Vázquez F; Villero J; Ferrer J; Ascaso C; Balasch J
Fertil Steril; 2007 Aug; 88(2):383-9. PubMed ID: 17561009
[TBL] [Abstract][Full Text] [Related]
11. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
[TBL] [Abstract][Full Text] [Related]
12. The effects of oral contraceptives including low-dose estrogen and drospirenone on the concentration of leptin and ghrelin in polycystic ovary syndrome.
Sağsöz N; Orbak Z; Noyan V; Yücel A; Uçar B; Yildiz L
Fertil Steril; 2009 Aug; 92(2):660-6. PubMed ID: 18973889
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamic effects of rosiglitazone in nondiabetic patients with metabolic syndrome.
Aquilante CL; Kosmiski LA; Zineh I; Rome LC; Knutsen SD
Pharmacotherapy; 2010 Mar; 30(3):236-47. PubMed ID: 20180607
[TBL] [Abstract][Full Text] [Related]
14. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
[TBL] [Abstract][Full Text] [Related]
15. Effects of the route of estrogen administration on insulinlike growth factor-I, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study.
Davis SR; Stuckey BG; Norman RJ; Papalia MA; Drillich A; Bell RJ
Menopause; 2008; 15(6):1065-9. PubMed ID: 18806686
[TBL] [Abstract][Full Text] [Related]
16. Oral, more than transdermal, estrogen therapy improves lipids and lipoprotein(a) in postmenopausal women: a randomized, placebo-controlled study.
Hemelaar M; van der Mooren MJ; Mijatovic V; Bouman AA; Schijf CP; Kroeks MV; Franke HR; Kenemans P
Menopause; 2003; 10(6):550-8. PubMed ID: 14627865
[TBL] [Abstract][Full Text] [Related]
17. Circulating levels of atherogenesis-associated adipocytokines and apoptotic markers are differentially influenced by hormone therapy, tibolone and raloxifene in healthy postmenopausal women.
Christodoulakos GE; Lambrinoudaki IV; Creatsa MG; Economou EV; Siasou Z; Panoulis CP; Kalligerou I; Papadias C
Climacteric; 2008 Apr; 11(2):155-65. PubMed ID: 18365858
[TBL] [Abstract][Full Text] [Related]
18. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins.
Vrablik M; Fait T; Kovar J; Poledne R; Ceska R
Metabolism; 2008 Aug; 57(8):1088-92. PubMed ID: 18640386
[TBL] [Abstract][Full Text] [Related]
19. Effects of treatment with testosterone alone or in combination with estrogen on insulin sensitivity in postmenopausal women.
Zang H; Carlström K; Arner P; Hirschberg AL
Fertil Steril; 2006 Jul; 86(1):136-44. PubMed ID: 16750207
[TBL] [Abstract][Full Text] [Related]
20. Estrogen replacement therapy decreases plasma adiponectin but not resistin in postmenopausal women.
Kunnari A; Santaniemi M; Jokela M; Karjalainen AH; Heikkinen J; Ukkola O; Kesäniemi YA
Metabolism; 2008 Nov; 57(11):1509-15. PubMed ID: 18940387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]